Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma

References

1. Dockter J., Evans C. F., Thison A., Oldstone M. B. A. 1996; Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. Journal of Virology 70:1799–1803
   [Google Scholar]
2. Enomoto N., Kurosaki M., Tanaka Y., Marumo F., Sato C. 1994; Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. Journal of General Virology 75:1361–1369
   [Google Scholar]
3. Fujii K., Hino K., Okazaki M., Okuda M., Kondoh S., Okita K. 1996; Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells. Biochemical and Biophysical Research Communications 225:771–776
   [Google Scholar]
4. Gonzales-Peralta R., Quian K., She J. Y., Davis G. L., Ohno T., Mizokami M., Lau J. Y. N. 1996; Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. Journal of Medical Virology 49:242–247
   [Google Scholar]
5. Horie C., Iwahana H., Horie T., Shimizu I., Yoshimoto K., Yogita S., Tashiro S., Ito S., Itakura M. 1996; Detection of different quasispecies of hepatitis C virus core region in cancerous and noncancerous lesions. Biochemical and Biophysical Research Communications 218:674–681
   [Google Scholar]
6. Kao J. H., Chen P. J., Lai M. Y., Wang T. H., Chen D. S. 1995; Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis. Journal of Infectious Diseases 172:261–264
   [Google Scholar]
7. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. 1990; Molecular cloning ofthe human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences USA: 87:9524–9528
   [Google Scholar]
8. Koizumi K., Enomoto N., Kurosaki M., Murakami T., Izumi N., Marumo F., Sato C. 1995; Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22:30–35
   [Google Scholar]
9. Kumar U., Monjardino J., Thomas H. C. 1994; Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 106:1072–1075
   [Google Scholar]
10. Kurosaki M., Enomoto N., Marumo F., Sato C. 1993; Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 18:1293–1299
    [Google Scholar]
11. Lerat H., Berby F., Trabaud M. A., Vidalin O., Major M., Trepo C., Inchauspe G. 1996; Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. Journal of Clinical Investigations 97:845–851
    [Google Scholar]
12. Moribe T., Hayashi N., Kanazawa Y., Mita E., Fusamoto H., Negi M., Kaneshige T., Igimi H., Kamada T., Uchida K. 1995; Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108:789–795
    [Google Scholar]
13. Okada S., Akahane Y., Suzuki H., Okamoto H., Mishiro S. 1992; The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619–624
    [Google Scholar]
14. Saito S., Kato N., Hijikata M., Gunji T., Itabashi M., Kondo M., Tanaka K., Shimotohno K. 1996; Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma. International Journal of Cancer 67:199–203
    [Google Scholar]
15. Sakamoto N., Enomoto N., Kurosaki M., Asahina Y., Maekawa S., Koizumi K., Sakuma I., Murakami F., Marumo T., Sato C. 1995; Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver. Journal of Medical Virology 46:7–11
    [Google Scholar]
16. Vatteroni M. L., Pistello M., Maggi F., Cecconi N., Panicucci F., Bendinelli M. 1994; Hepatitis C virus serological and polymerase chain reactions in human immunodeficiency virus-positive and negative patients. Clinical and Diagnostic Virology 2:7–16
    [Google Scholar]
17. Weiner A. J., Geysen H. M., Christopherson C., Hall J. E., Mason T. J., Saracco G., Bonino F., Crawford K., Marion C. D., Crawford K. A., Brunetto M., Barr P. J., Miyamura T., McHutchinson J., Houghton M. 1992; Evidence for immune selection of hepatitis C virus putative envelope glycoprotein variants: potential role in chronic HCV infection. Proceedings of the National Academy of Sciences USA: 89368–372
    [Google Scholar]
18. Yun Z. B., Odeberg J., Lundeberg J., Weiland O., Uhlen M., Sonnerborg A. 1996; Restriction of hepatitis C virus heterogeneity during prolonged interferon-a therapy in relation to changes in virus load. Journal of Infectious Diseases 173:992–996
    [Google Scholar]